AU2002223170A1 - Pharmaceutical composition and method for treatment of brain injury, spinal cord injury, stroke, neurodegenerative disease and other conditions - Google Patents

Pharmaceutical composition and method for treatment of brain injury, spinal cord injury, stroke, neurodegenerative disease and other conditions

Info

Publication number
AU2002223170A1
AU2002223170A1 AU2002223170A AU2317002A AU2002223170A1 AU 2002223170 A1 AU2002223170 A1 AU 2002223170A1 AU 2002223170 A AU2002223170 A AU 2002223170A AU 2317002 A AU2317002 A AU 2317002A AU 2002223170 A1 AU2002223170 A1 AU 2002223170A1
Authority
AU
Australia
Prior art keywords
stroke
treatment
conditions
pharmaceutical composition
spinal cord
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002223170A
Inventor
Milos Pekny
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002223170A1 publication Critical patent/AU2002223170A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2285—Endothelin, vasoactive intestinal contractor [VIC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002223170A 2000-12-01 2001-11-30 Pharmaceutical composition and method for treatment of brain injury, spinal cord injury, stroke, neurodegenerative disease and other conditions Abandoned AU2002223170A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0004455-2 2000-12-01
SE0004455A SE0004455D0 (en) 2000-12-01 2000-12-01 Method of neuronal regeneration in the central nervous system
PCT/SE2001/002656 WO2002043654A2 (en) 2000-12-01 2001-11-30 Pharmaceutical composition and method for treatment of brain injury, spinal cord injury, stroke, neurodegenerative disease and other conditions

Publications (1)

Publication Number Publication Date
AU2002223170A1 true AU2002223170A1 (en) 2002-06-11

Family

ID=20282072

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002223170A Abandoned AU2002223170A1 (en) 2000-12-01 2001-11-30 Pharmaceutical composition and method for treatment of brain injury, spinal cord injury, stroke, neurodegenerative disease and other conditions

Country Status (3)

Country Link
AU (1) AU2002223170A1 (en)
SE (1) SE0004455D0 (en)
WO (1) WO2002043654A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2614813T3 (en) 2009-04-30 2017-06-02 Midwestern University New therapeutic treatments using centaquine
US10561704B2 (en) * 2013-07-08 2020-02-18 Midwestern University Compositions and methods for treating neuropsychiatric disorders using an endothelin-B receptor agonist
US20150190377A1 (en) * 2014-01-06 2015-07-09 The Regents Of The University Of California, A California Corporation Neuronal regeneration
WO2016172952A1 (en) 2015-04-30 2016-11-03 江苏挪贝肽医药科技有限公司 Application of pi4kiiiα protein and related membrane protein complex in treating alzheimer's disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043224A (en) * 1996-09-05 2000-03-28 The Massachusetts Institute Of Technology Compositions and methods for treatment of neurological disorders and neurodegenerative diseases
WO1998029547A1 (en) * 1996-12-31 1998-07-09 The Rockefeller University Modulators of radial glia-astrocyte differentiation and transformation, and diagnostic and therapeutic uses thereof
DE19751949A1 (en) * 1997-11-24 1999-05-27 Bayer Ag Neuronal regeneration and neurodegenerative disease treatment with aminomethyl-chroman derivatives

Also Published As

Publication number Publication date
SE0004455D0 (en) 2000-12-01
WO2002043654A2 (en) 2002-06-06
WO2002043654A3 (en) 2002-09-06
WO2002043654A8 (en) 2004-04-01

Similar Documents

Publication Publication Date Title
AU2002335736A1 (en) Composition and treatment method for brain and spinal cord injuries
HK1054872A1 (en) Brain, spinal and nerve injury treatment
AUPR638101A0 (en) Composition and method for treatment of disease
ZA200107315B (en) Pharmaceutical combinations for the treatment of stroke and traumatic brain injury.
AU2001261637A1 (en) Apparatus for treatment of spinal disorders
AU2003246102A1 (en) Method of examining allergic disease and drug for treating the same
WO2002086502A8 (en) Methods for the diagnosis and treatment of bone disorders
AU2001227837A1 (en) Novel treatment for eye disease
IL173123A0 (en) System and method for the photodynamic treatment of burns, wounds, and related skin disorders
EP1427474A4 (en) Apparatus and method for bioelectric stimulation, healing acceleration and pain relief
AU2003280063A1 (en) Method for eradicating pain of central origin resulting from spinal cord injury
WO2002064126A3 (en) Method of treating of demyelinating diseases or conditions
AU2000277906A1 (en) Method and apparatus for surgical treatment of diseases of the vertebral column,especially scoliosis, using anterior endoscopic technique
AU2002241343A1 (en) Decoy compositions for treating and preventing brain diseases and disorders
AU2002223170A1 (en) Pharmaceutical composition and method for treatment of brain injury, spinal cord injury, stroke, neurodegenerative disease and other conditions
AU2002322263A1 (en) Eglin c based drugs for treatment of disease
AUPP870999A0 (en) Method of treatment of equine disease
AU4654500A (en) Prevention, diagnosis and treatment of lyme disease
AU1574701A (en) A pharmaceutical composition containing pglu-glu-pro-nh2 and method for treating diseases and injuries to the brain, spinal cord and retina using same
AU2002243883A1 (en) Cholesterol-lowering agents as treatment for psychological and cognitive disorders
AU2002246117A1 (en) Method for treatment and diagnosis of eye tissues
AU2003290970A1 (en) Compositions and method for treating affective, painful or allergic disorders
AU4800500A (en) Method for treatment of lyme disease
AU2003222326A1 (en) Composition for transporting oligonucleotides through the blood brain barrier and their use for treating central nervous system diseases
TWI345980B (en) Pharmaceutical compositions for preventing or treating injuries of brain tissue